OUE Lippo Healthcare

OUE Lippo Healthcare swings back into the black in 1Q

SINGAPORE (May 8): OUE Lippo Healthcare (OUE LH) has posted $0.2 million earnings, reversing from its 1Q18 loss of $2.7 million due to lower finance costs, higher other income as well as higher share of results of equity-accounted investees.

This comes despite a 7.3% decline in revenue to $4.8 million from $5.2 million previously, which came on the back of lower revenue from the group’s China pharmaceutical distribution business although revenue from rental of its Japan nursing facilities remained stable y-o-y.

OUE Lippo Healthcare started at 'buy' on improving earnings visibility

SINGAPORE (Mar 11): Soochow CSSSD Capital Markets (SCCM) is starting coverage on OUE Lippo Healthcare (OUE LH) at “buy” with a target price of 8.8 cents, while forecasting a 25.2% earnings per share (EPS) CAGR from FY19-22E as the group enters a “durable earnings expansion phase”, in the research house’s words.  

Based on the research house’s valuations, the stock currently trades at an attractive 1.1 times price-to-book versus the industry average of 3.8 times.

Winners and losers from Singapore's budget as election looms

SINGAPORE (Feb 19): Singapore Finance Minister Heng Swee Keat boosted health-care and military spending, gave tax rebates to citizens and tightened rules on foreign workers ahead of an election that could come as early as this year.

Heng announced a new $8 billion support package for seniors in his budget speech on Monday, as well as measures to help local businesses adopt new technologies. The expansionary fiscal plan will push the overall budget deficit to 0.7% of gross domestic product in the year ending March 2020, from a revised surplus of 0.4% this year.

OUE Lippo Healthcare JV to manage 3 hospitals in major Chinese cities

SINGAPORE (Dec 31): OUE Lippo Healthcare will manage three medical facilities in Shanghai, Chongqing and Nanjing through to a joint-venture agreement.

Named China Merchants Lippo Hospital Management (Shenzhen), the company is a 50:50 JV between OUE Lippo’s indirect wholly-owned subsidiary Lippo Healthcare and China Merchants Landmark (Shenzhen), a member of China Merchants Group (CMG).

More challenges loom for First REIT after completion of ownership restructuring: OCBC

SINGAPORE (Dec 13): OCBC Investment Research is maintaining its “hold” call on First REIT with a lower fair value of $1.05 from $1.34 previously, after factoring in various risks pertaining to the REIT’s master leases and portfolio balancing.  

OUE Lippo Healthcare and China Merchants Group to develop, operate Shenzhen hospital

SINGAPORE (Dec 12): OUE Lippo Healthcare has entered into a non-binding letter of intent (LOI) with China Merchants Shekou Industrial Zone Holdings, to jointly develop, operate and manage a high-end international hospital in Shenzhen, China.

The hospital located in Shekou is expected have more than 200 beds serving the local community, and tapping into the medical tourism industry in the Guangdong-Hong Kong-Macao Greater Bay Area.

Indonesia billionaire family reshuffles empire on currency rout

SINGAPORE/JAKARTA (Sept 19): Southeast Asia’s billionaire Riady family is reshuffling its health-care holdings as its core property business grapples with the emerging-market rout.

OUE Lippo Healthcare FY17 losses widen to $90.7 mil on lower revenue & higher costs

SINGAPORE (Feb 12): OUE Lippo Healthcare further sunk into the red in FY17 with a loss of $90.7 million, 18% down from its loss of $76.8 million the previous year on lower revenue and higher costs of sales.

Revenue for the full year declined 11.2% to $43.6 million, due mainly to lower rental contributions from investment properties in Australia. This was however partially offset by higher contributions from operating Wuxi New District Phoenix Hospital, while income from the group’s nursing facilities In Japan remained stable.   

OUE Lippo Healthcare to appeal Shanghai courts' judgment on Weixin claim

SINGAPORE (Dec 20): OUE Lippo Healthcare, the former International Healthway Corporation (IHC), says the Shanghai courts had rendered a first instance judgment in favour of Weixin Hospital Investment Management (Shanghai) Co. regarding claims to two subsidiaries under IHC.

Announced on Feb 22, the claims were against Shanghai Yi Lin Medical Management Consulting Co and Wuxi New District Phoenix Hospital Co by Weixin, a company controlled by David Lin Kao Kun.

OUE Lippo Healthcare ordered to repay alleged outstanding loan

SINGAPORE (Nov 23): OUE Lippo Healthcare, formerly known as International Healthway Corporation (IHC), has been ordered to pay RMB6 million ($1.2 million) plus interest for a claim brought against one of its downstream subsidiaries, Wuxi New District Phoenix Hospital.

The claimant, David Lin, alleges that he had previously granted Wuxi Hospital a loan in 2012 through the Bank of Nanjing, Shanghai Branch, and that an outstanding sum of RMB6 million has yet to be repayed.

Be informed of the stories that matter


Be informed of the stories that matter